What is the Bliss GVS Pharma Ltd share price today?

The share price of NSE:BLISSGVS-BE on 07 Sep 2026 (as of 10:58:57 IST) is ₹689.00.

What is the NSE:BLISSGVS-BE 52 week high low price?

Over the past 52 weeks (as of 07 Sep 2026), the NSE:BLISSGVS-BE 52 week high low range shows a high of ₹704.55 and a low of ₹118.00.

What is the Bliss GVS Pharma Ltd market cap?

As on 07 Sep 2026, Bliss GVS Pharma Ltd market cap is ₹7110.32 Cr.

What is the shareholding pattern of Bliss GVS Pharma Ltd Stock?

The shareholding pattern of Bliss GVS Pharma Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 35.01% Foreign Institutional Investors (FII): 8.07% Domestic Institutional Investors (DII): 9.06% Mutual Funds: 0.26% Retail & Others: 47.60% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Bliss GVS Pharma Ltd?

The Price-to-Earnings (PE) ratio of Bliss GVS Pharma Ltd is 52.21, and the Price-to-Book (PB) ratio is 1.93, as on 07 Sep 2026.

Bliss GVS Pharma Share Price

687.05-12.15 (-1.74%)

+354.34% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-1.74%

1 Week

+0.76%

1 Month

+22.36%

3 Month

+39.66%

6 Month

+215.19%

YTD

+320.50%

1 Year

+354.34%

5 Year

+516.46%

10 Year

+372.69%

Max

+1537.78%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

680.00

651.55

555.00

443.00

214.13

118.00

High

707.75

717.00

728.00

About

Bliss GVS Pharma Limited is a fast-growing Pharmaceutical Company with a proven track record of developing manufacturing and marketing high quality pharmaceutical formulations at affordable prices for the global market. Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

ZYDUSLIFENSE

CIPLANSE

LAURUSLABSNSE

MANKINDNSE

DRREDDYNSE

AUROPHARMANSE

LUPINNSE

BLISSGVS-BENSE

LTP

1W Low

1W High

Market cap (₹)

1849.9+12.6 (0.69%)

1832.20

1891.50

4,47,476Cr

9602+227 (2.42%)

9312.50

9740

2,54,764Cr

4928.5+88.5 (1.83%)

4848.50

5010

1,89,423Cr

1180.3+20.3 (1.75%)

1152.10

1190.60

1,16,658Cr

1399+4.5 (0.32%)

1364.50

1419

1,11,484Cr

2026.2+72.2 (3.69%)

1963.80

2055.30

1,09,943Cr

2500+199.3 (8.66%)

2303

2504.30

1,01,712Cr

1200.4+15.4 (1.30%)

1185

1222

1,01,005Cr

1716-18 (-1.04%)

1689.30

1740

99,253Cr

2100.7+17.7 (0.85%)

2080

2135

96,031Cr

685.1+3.25 (0.48%)

651.55

717

7,411Cr

Bliss GVS Pharma Share Price

687.05-12.15 (-1.74%)

+354.34% past 1 Year

Financial overview

Compounded Sales Growth

10 years5%

5 years10%

3 years7%

Last year14%

Compounded Profit Growth

10 years5%

5 years14%

3 years22%

Last year49%

Stock Price CAGR

10 years17%

5 years44%

3 years97%

1 year362%

Return on Equity

10 years13%

5 years8%

3 years10%

Last year12%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
5%	10%	7%	14%
5%	14%	22%	49%
17%	44%	97%	362%
13%	8%	10%	12%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

ZYDUSLIFE

CIPLA

LAURUSLABS

MANKIND

DRREDDY

AUROPHARMA

LUPIN

BLISSGVS-BE

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,866.7	₹447476 Cr	37	12.07	62.82	₹11479 Cr
9,654.5	₹254764 Cr	87.1	34.04	128.41	₹2568 Cr
4,970	₹189423 Cr	86.85	16.72	97.06	₹2163 Cr
1,170.1	₹116658 Cr	25.85	9.42	62.53	₹5040 Cr
1,391.5	₹111484 Cr	33.08	9.77	57.87	₹3879 Cr
2,051.1	₹109943 Cr	100.55	6.8	29.25	₹889 Cr
2,482.7	₹101712 Cr	49.79	13.75	71.08	₹1913 Cr
1,207.9	₹101005 Cr	31.35	5.32	63.99	₹4196 Cr
1,734.1	₹99253 Cr	26.73	17.95	96.84	₹3505 Cr
2,104.8	₹96031 Cr	17.37	30.95	154.35	₹5333 Cr
686.85	₹7411 Cr	54.42	4.72	16.12	₹129 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Miscellaneous Expenses not written off

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹11 Cr	₹11 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr
₹12 Cr	₹6 Cr	₹8 Cr	₹9 Cr	₹10 Cr	₹10 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹1171 Cr	₹1034 Cr	₹949 Cr	₹865 Cr	₹798 Cr	₹788 Cr	₹725 Cr	₹636 Cr	₹526 Cr	₹476 Cr	₹402 Cr	₹327 Cr	₹277 Cr	₹248 Cr	₹200 Cr	₹156 Cr
₹1171 Cr	₹1034 Cr	₹949 Cr	₹865 Cr	₹798 Cr	₹788 Cr	₹725 Cr	₹636 Cr	₹526 Cr	₹476 Cr	₹402 Cr	₹327 Cr	₹277 Cr	₹248 Cr	₹200 Cr	₹156 Cr
₹1193 Cr	₹1050 Cr	₹967 Cr	₹884 Cr	₹819 Cr	₹808 Cr	₹736 Cr	₹646 Cr	₹536 Cr	₹487 Cr	₹413 Cr	₹337 Cr	₹287 Cr	₹258 Cr	₹211 Cr	₹167 Cr
₹39 Cr	₹41 Cr	₹36 Cr	₹34 Cr	₹28 Cr	₹20 Cr	₹15 Cr	₹14 Cr	₹11 Cr	₹66 Cr	₹33 Cr	₹15 Cr	₹10 Cr	₹14 Cr	₹49,000	₹0
₹0	₹20 Cr	₹36 Cr	₹41 Cr	₹23 Cr	₹33 Cr	₹37 Cr	₹33 Cr	₹6 Cr	₹26 Cr	₹30 Cr	₹55 Cr	₹79 Cr	₹90 Cr	₹38 Cr	₹4 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹9 Cr	₹2 Cr	₹9 Cr	₹1 Cr	₹0	₹0
-₹16 Cr	₹30 L	₹4 Cr	-₹3 Cr	₹1 Cr	₹8 Cr	₹4 Cr	₹4 Cr	₹5 Cr	₹5 Cr	₹9 Cr	₹9 Cr	₹7 Cr	₹5 Cr	₹1 Cr	-₹37 L
₹22 Cr	₹13 Cr	₹9 Cr	₹3 Cr	₹4 Cr	₹2 Cr	₹3 Cr	₹13 L	₹0	₹40,000	₹0	₹0	₹0	₹0	₹0	₹0
₹3 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹1 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹74 L	₹51 L	₹58 L
₹9 Cr	₹37 Cr	₹51 Cr	₹43 Cr	₹29 Cr	₹45 Cr	₹46 Cr	₹38 Cr	₹13 Cr	₹33 Cr	₹50 Cr	₹68 Cr	₹96 Cr	₹97 Cr	₹39 Cr	₹4 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹104 Cr	₹71 Cr	₹61 Cr	₹86 Cr	₹93 Cr	₹74 Cr	₹90 Cr	₹79 Cr	₹58 Cr	₹98 Cr	₹108 Cr	₹80 Cr	₹82 Cr	₹118 Cr	₹40 Cr	₹31 Cr
₹94 Cr	₹73 Cr	₹62 Cr	₹58 Cr	₹68 Cr	₹54 Cr	₹57 Cr	₹50 Cr	₹124 Cr	₹100 Cr	₹53 Cr	₹70 Cr	₹42 Cr	₹24 Cr	₹6 Cr	₹4 Cr
₹3 Cr	₹23 Cr	₹32 Cr	₹46 Cr	₹61 Cr	₹65 Cr	₹66 Cr	₹64 Cr	₹106 Cr	₹187 Cr	₹62 Cr	₹61 Cr	₹57 Cr	₹45 Cr	₹6 Cr	₹3 Cr
₹35 Cr	₹4 Cr	₹2 Cr	₹3 Cr	₹12 Cr	₹11 Cr	₹17 Cr	₹14 Cr	₹11 Cr	₹51 Cr	₹156 Cr	₹31 Cr	₹126 Cr	₹14 Cr	₹8 Cr	₹4 Cr
₹236 Cr	₹172 Cr	₹157 Cr	₹193 Cr	₹233 Cr	₹204 Cr	₹231 Cr	₹207 Cr	₹299 Cr	₹437 Cr	₹379 Cr	₹243 Cr	₹308 Cr	₹202 Cr	₹60 Cr	₹43 Cr
₹1476 Cr	₹1301 Cr	₹1212 Cr	₹1154 Cr	₹1109 Cr	₹1077 Cr	₹1027 Cr	₹905 Cr	₹860 Cr	₹1023 Cr	₹874 Cr	₹662 Cr	₹700 Cr	₹571 Cr	₹310 Cr	₹213 Cr
₹11 Cr	₹5 Cr	₹57 Cr	₹12 Cr	₹23 Cr	₹30 Cr	₹14 Cr	₹2 Cr	₹4 Cr	₹44 Cr	₹30 Cr	₹40 Cr	₹48 Cr	₹44 Cr	₹51 Cr	₹12 Cr
₹3 Cr	₹71 Cr	₹88 Cr	₹98 Cr	₹105 Cr	₹119 Cr	₹121 Cr	₹102 Cr	₹118 Cr	₹225 Cr	₹132 Cr	₹160 Cr	₹173 Cr	₹147 Cr	₹45 Cr	₹8 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹607 Cr	₹531 Cr	₹468 Cr	₹459 Cr	₹343 Cr	₹285 Cr	₹276 Cr	₹170 Cr	₹157 Cr	₹327 Cr	₹301 Cr	₹294 Cr	₹262 Cr	₹206 Cr	₹64 Cr	₹41 Cr
₹149 Cr	₹126 Cr	₹98 Cr	₹81 Cr	₹63 Cr	₹51 Cr	₹35 Cr	₹25 Cr	₹21 Cr	₹23 Cr	₹75 Cr	₹59 Cr	₹49 Cr	₹38 Cr	₹24 Cr	₹21 Cr
₹459 Cr	₹405 Cr	₹369 Cr	₹378 Cr	₹281 Cr	₹234 Cr	₹241 Cr	₹145 Cr	₹136 Cr	₹304 Cr	₹225 Cr	₹234 Cr	₹213 Cr	₹168 Cr	₹40 Cr	₹20 Cr
₹6 Cr	₹21 Cr	₹8 Cr	₹3 Cr	₹22 Cr	₹2 Cr	₹0	₹47 Cr	₹47 L	₹4 Cr	₹9 Cr	₹0	₹4 Cr	₹65 L	₹6 Cr	₹8 Cr
₹4 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹2 Cr	₹1 L	₹72 L	₹72 L	₹6 Cr	₹1 Cr	₹11 L	₹1 L	₹1 L	₹1 L	₹1,000	₹1,000
₹4 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹2 Cr	₹1 L	₹72 L	₹72 L	₹6 Cr	₹1 Cr	₹11 L	₹1 L	₹1 L	₹1 L	₹1,000	₹1,000
₹30 Cr	₹20 Cr	₹15 Cr	₹18 Cr	₹24 Cr	₹13 Cr	₹15 Cr	₹19 Cr	₹27 Cr	₹11 Cr	₹57 Cr	₹10 Cr	₹12 Cr	₹51 Cr	₹53 Cr	₹29 Cr
₹31 Cr	₹27 Cr	₹5 Cr	₹54 Cr	₹1 Cr	₹62 Cr	₹1 Cr	₹33 L	₹29 L	₹137 Cr	₹0	₹0	₹0	₹0	₹0	₹0
₹530 Cr	₹477 Cr	₹401 Cr	₹456 Cr	₹332 Cr	₹312 Cr	₹257 Cr	₹211 Cr	₹170 Cr	₹457 Cr	₹291 Cr	₹245 Cr	₹230 Cr	₹220 Cr	₹100 Cr	₹57 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹1 Cr	₹0	₹56 L	₹5 Cr	₹0	₹0	₹0	₹0	₹0	₹1,000	₹0	₹0	₹0	₹0	₹80 L	₹0
₹151 Cr	₹126 Cr	₹118 Cr	₹103 Cr	₹124 Cr	₹99 Cr	₹74 Cr	₹77 Cr	₹59 Cr	₹49 Cr	₹39 Cr	₹34 Cr	₹33 Cr	₹33 Cr	₹13 Cr	₹12 Cr
₹517 Cr	₹439 Cr	₹404 Cr	₹385 Cr	₹393 Cr	₹464 Cr	₹548 Cr	₹461 Cr	₹298 Cr	₹254 Cr	₹301 Cr	₹247 Cr	₹215 Cr	₹245 Cr	₹129 Cr	₹120 Cr
₹167 Cr	₹213 Cr	₹216 Cr	₹103 Cr	₹178 Cr	₹145 Cr	₹103 Cr	₹107 Cr	₹89 Cr	₹151 Cr	₹78 Cr	₹57 Cr	₹80 Cr	₹50 Cr	₹58 Cr	₹18 Cr
₹14 Cr	₹15 Cr	₹17 Cr	₹7 Cr	₹14 Cr	₹18 Cr	₹16 Cr	₹26 Cr	₹97 Cr	₹33 Cr	₹15 Cr	₹18 Cr	₹11 Cr	₹12 Cr	₹4 Cr	₹5 Cr
₹96 Cr	₹24 Cr	₹55 Cr	₹95 Cr	₹69 Cr	₹40 Cr	₹28 Cr	₹23 Cr	₹146 Cr	₹78 Cr	₹150 Cr	₹61 Cr	₹130 Cr	₹9 Cr	₹5 Cr	₹3 Cr
₹946 Cr	₹817 Cr	₹811 Cr	₹697 Cr	₹777 Cr	₹765 Cr	₹770 Cr	₹693 Cr	₹690 Cr	₹566 Cr	₹583 Cr	₹417 Cr	₹469 Cr	₹349 Cr	₹210 Cr	₹157 Cr
₹711 Cr	₹644 Cr	₹653 Cr	₹504 Cr	₹544 Cr	₹562 Cr	₹539 Cr	₹486 Cr	₹390 Cr	₹129 Cr	₹204 Cr	₹174 Cr	₹162 Cr	₹147 Cr	₹150 Cr	₹114 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹43 L	₹1 Cr	₹2 Cr	₹0	₹0
₹1476 Cr	₹1301 Cr	₹1212 Cr	₹1154 Cr	₹1109 Cr	₹1077 Cr	₹1027 Cr	₹905 Cr	₹860 Cr	₹1023 Cr	₹874 Cr	₹662 Cr	₹700 Cr	₹571 Cr	₹310 Cr	₹213 Cr
₹112	₹99	₹92	₹84	₹78	₹77	₹71	₹63	₹52	₹47	₹40	₹33	₹28	₹25	₹20	₹16
₹112	₹99	₹92	₹84	₹78	₹77	₹71	₹63	₹52	₹47	₹40	₹33	₹28	₹25	₹20	₹16

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011
₹190 Cr	₹126 Cr	₹146 Cr	₹106 Cr	₹128 Cr	₹104 Cr	₹129 Cr	₹182 Cr	₹179 Cr	₹175 Cr	₹148 Cr	₹96 Cr	₹71 Cr	₹109 Cr	₹79 Cr	₹0
₹96 Cr	₹71 Cr	₹38 Cr	₹58 Cr	-₹32 Cr	₹46 Cr	₹27 Cr	-₹11 Cr	₹18 Cr	₹36 Cr	₹18 Cr	₹17 Cr	₹24 Cr	₹10 Cr	₹5 Cr	₹0
-₹104 Cr	-₹51 Cr	-₹47 Cr	-₹85 Cr	₹73 Cr	-₹58 Cr	-₹70 Cr	-₹183 Cr	-₹141 Cr	₹113 Cr	-₹8 Cr	-₹67 Cr	-₹19 Cr	-₹74 Cr	-₹38 Cr	₹0
₹181 Cr	₹145 Cr	₹138 Cr	₹79 Cr	₹169 Cr	₹93 Cr	₹85 Cr	-₹12 Cr	₹56 Cr	₹325 Cr	₹158 Cr	₹46 Cr	₹75 Cr	₹45 Cr	₹46 Cr	₹0
₹139 Cr	₹106 Cr	₹103 Cr	₹34 Cr	₹135 Cr	₹64 Cr	₹47 Cr	₹40 Cr	₹18 Cr	₹289 Cr	₹113 Cr	₹38 Cr	₹41 Cr	₹7 Cr	₹35 Cr	₹0
-₹38 Cr	-₹76 Cr	-₹83 Cr	-₹8 Cr	-₹93 Cr	-₹47 Cr	-₹48 Cr	-₹74 Cr	₹50 Cr	-₹231 Cr	-₹50 Cr	-₹29 Cr	-₹11 Cr	-₹124 Cr	-₹22 Cr	₹0
-₹89 Cr	-₹30 Cr	-₹21 Cr	-₹25 Cr	-₹24 Cr	-₹21 Cr	-₹6 Cr	₹17 Cr	-₹76 Cr	-₹10 Cr	-₹40 Cr	-₹42 Cr	-₹8 Cr	₹110 Cr	₹26 Cr	₹0
₹11 Cr	₹13 L	-₹1 Cr	₹2 Cr	₹19 Cr	-₹4 Cr	-₹7 Cr	-₹17 Cr	-₹8 Cr	₹48 Cr	₹23 Cr	-₹33 Cr	₹22 Cr	-₹8 Cr	₹40 Cr	₹0
₹24 Cr	₹24 Cr	₹25 Cr	₹22 Cr	₹13 Cr	₹15 Cr	₹15 Cr	₹37 Cr	₹47 Cr	₹0	₹5 Cr	₹39 Cr	₹28 Cr	₹58 Cr	₹18 Cr	₹0
₹0	₹0	₹0	₹0	₹0	₹0	₹5 L	₹0	₹0	₹17 Cr	₹0	₹0	₹0	₹0	₹0	₹0
₹10 L	₹10 L	-₹15 L	₹1 Cr	-₹10 Cr	₹2 Cr	₹8 Cr	-₹5 Cr	-₹2 Cr	-₹18 Cr	-₹34 L	-₹53 L	₹0	₹0	₹0	₹0
₹35 Cr	₹24 Cr	₹24 Cr	₹25 Cr	₹22 Cr	₹13 Cr	₹15 Cr	₹15 Cr	₹37 Cr	₹47 Cr	₹28 Cr	₹5 Cr	₹50 Cr	₹50 Cr	₹58 Cr	₹0

Fundamental Ratios

Consolidated

Standalone

No results found

Bliss GVS Pharma Share Price

687.05-12.15 (-1.74%)

+354.34% past 1 Year

Shareholding summary

Promoters

35.01%

FII

8.07%

DII

9.06%

0.26%

Others

47.6%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
35.01%	35.36%	35.36%	35.39%	35.44%	35.29%
8.07%	10.45%	14.54%	13.27%	12.65%	13.18%
9.06%	5.04%	5.78%	5.98%	6.54%	6.55%
0.26%	0.00%	0.00%	0.00%	0.00%	0.00%
47.60%	49.15%	44.32%	45.36%	45.37%	44.98%

Bulk & block deals

Name

Nova Vida Limited

Arian Investment Ltd

Nova Vida Limited

Arian Investment Ltd

Mateus Ltd

Arian Investment Ltd

Mateus Ltd

Arian Investment Ltd

Hrti Private Limited

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
21 Jul 2026	Purchase	33.95 Cr	₹485	7 L	Bulk	0.658325	NSE
21 Jul 2026	Sell	33.95 Cr	₹485	7 L	Bulk	0.658325	NSE
21 Jul 2026	Purchase	33.95 Cr	₹485	7 L	Block	0.658325	NSE
21 Jul 2026	Sell	33.95 Cr	₹485	7 L	Block	0.658325	NSE
29 Jun 2026	Purchase	56.35 Cr	₹490	11.50 L	Bulk	1.081534	NSE
29 Jun 2026	Sell	56.35 Cr	₹490	11.50 L	Bulk	1.081534	NSE
29 Jun 2026	Purchase	56.35 Cr	₹490	11.50 L	Block	1.081534	NSE
29 Jun 2026	Sell	56.35 Cr	₹490	11.50 L	Block	1.081534	NSE
29 May 2026	Purchase	19.20 Cr	₹419.26	4.58 L	Bulk	0.430731	NSE
29 May 2026	Sell	23.67 Cr	₹420.49	5.63 L	Bulk	0.529418	NSE

Insider trading & SAST

Client name

Life Insurance Corporation Of India

Clarus Capital I & Others

Gagan Harsh Sharma & Pacs

Punita Sharma & Pacs

Mr. Gagan Harsh Sharma

Mrs. Punita Sharma

Mr. Gagan Harsh Sharma

Gagan Harsh Sharma & Pacs

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
24 Aug 2026	Other	Disposal	2.15	2.95	0	—	21.32 L	09 Sep 2020 - 10 Aug 2026	Market	31,44,284	SAST	29(2)	—
31 Jul 2026	Other	Acquisition	0.17	5.13	0	—	1.85 L	20 Jul 2026	Market	54,38,523	SAST	29(1)	—
17 Jun 2026	Promoter	Disposal	0.21	—	0	—	2.17 L	18 May 2026	Market	—	SAST	29(2)	—
27 May 2026	Promoter	Disposal	0.02	—	0	—	24.96 K	18 May 2026	Market	—	SAST	29(2)	—
21 May 2026	Promoter	Disposal	0.205242	0	6.20 Cr	₹285.78	2.17 L	18 May 2026	Market Sale	0	Insider Trading	—	Equity Shares
21 May 2026	Promoter Group	Disposal	0.023596	0	71.14 L	₹285	24.96 K	18 May 2026	Market Sale	0	Insider Trading	—	Equity Shares
23 Dec 2025	Promoter	Acquisition	0.002007	0.2	2.99 L	₹140.94	2.12 K	16 Dec 2025	Market Purchase	2,17,123	Insider Trading	—	Equity Shares
18 Dec 2025	Promoter	Acquisition	0.004726	0.2	7.11 L	₹142.10	5 K	15 Dec 2025	Market Purchase	2,15,000	Insider Trading	—	Equity Shares
18 Dec 2025	Promoter	Acquisition	0.009453	0.19	14.41 L	₹144.10	10 K	12 Dec 2025	Market Purchase	2,10,000	Insider Trading	—	Equity Shares
16 Jul 2025	Promoter	Acquisition	0.03	35.45	0	—	34.98 K	25 Jun 2025 - 27 Jun 2025	Market	3,73,87,174	SAST	29(1)	—

Bliss GVS Pharma Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Bliss GVS Pharma Share Price

Bliss GVS Pharma Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Bliss GVS Pharma Share Price

Bliss GVS Pharma Share Price

Oscillators

Moving averages

Bliss GVS Pharma Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Bliss GVS Pharma Share Price

Corporate Actions

Company details

Bliss GVS Pharma Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Bliss GVS Pharma Share Price

News

Bliss GVS Pharma informs about open offer

Bliss GVS Pharma rises on securing Inspection Closure Report from WHO

Bliss GVS Pharma gains WHO GMP compliance approval for Palghar facility

Bliss GVS Pharma informs about disclosure

Bliss GVS Pharma Q4 Consolidated Net Profit Rises to Rs 35.50 Crores, Up from Rs 15.50 Crores YoY

Bliss GVS Pharma Reports Q4 Revenue Growth to Rs 257 Crores, Up from Rs 198 Crores YoY

Bliss GVS Pharma Reports Strong Q4 EBITDA Growth to Rs 44.40 Crores, Margin Expands to 17.3%

Bliss GVS Pharma reports Profit after tax of 32.42 Crores, in the March 2026 quarter

Bliss GVS Pharma informs about credit rating

Bliss GVS Pharma informs about trading window closure

Bliss GVS Pharma Addresses Rumors of Acquiring Anupam Rasayan, No Official Decision Yet.

Anupam Rasayan May Acquire Stake in Bliss GVS Pharma as per CNBC Aawaz Report.

Bliss GVS Pharma - Quaterly Results

Bliss GVS Pharma Reports Strong Q3 EBITDA Growth of 16% YoY to Rs 34.80 Crores.

Bliss GVS Pharma Reports Q3 Revenue Growth to Rs 220 Crores, Up from Rs 210 Crores YoY.

Bliss GVS Pharma Q3 FY26 Net Profit Declines YoY to Rs 23.30 Crores

Bliss GVS Pharma reports Profit after tax of 18.61 Crores, in the December 2025 quarter

Bliss GVS Pharma Establishes Wholly Owned Subsidiary in Democratic Republic of Congo

Bliss GVS Pharma’s arm incorporates wholly owned subsidiary in Kenya

Bliss GVS Pharma Establishes Theralife Pharma in Kenya

Bliss GVS Pharma Ltd Share Price Today

Bliss GVS Pharma Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator